A comprehensive look at discussions on #menopause by @FastCompany's @ainsleyoc featuring @celmatix "One of the biggest lies in healthcare today is that menopause is a natural phenomenon"...@pirayebeim says. In her eyes, it’s a “public health crisis.”
https://t.co/fZt8kh6Iyr
We regularly discuss the complicated health toll of #menopause on women, now a new study from @MayoClinic uncovers a sizable financial toll as well. Findings reveal menopause is estimated to cost $1.8 billion in the US annually #endmenopause https://t.co/WDlwBPzYXp
Wonderful to be included in @NewYorker's “The Future of Fertility” piece this month w/ @celmatix Founder @pirayebeim's perspective on what the future of #fertility could truly hold, & the critical work needed to address women's reproductive longevity.
https://t.co/z9eB85zpJm
🚀 Biotech company @Celmatix launches novel PCOS drug program targeting melatonin receptors
More on this: https://t.co/JHXZFjJuaP
#biotech#pcos#ovarianbiology
Celmatix's #melatonin drug program addresses a critical gap in the market for effective treatments for a range of women’s health indications, starting w/ #PCOS, w/ the potential to expand into the treatment of #endometriosis and #menopausal symptoms. https://t.co/7PUCRelbbS
A behind-the-scenes look at today's interview w/ @OprahDaily as @pirayebeim shares more on the role of the #ovary & why @celmatix is working to end #menopause. We're excited for the interview to come out next week along w/ other announcements from our team. Stay tuned!
‼️ OUT TODAY @NatureGenet
📰 The genetic basis of #endometriosis and comorbidity with other pain and inflammatory conditions
🧑🏽🤝🧑🏼 @Nilosh @KrinaZondervan @Ox_wrh
and colleagues
⬇️
https://t.co/ht0SdzTrOU
Celmatix & collaborators announced findings today in @NatureGenet on the #genetic basis of #endometriosis. Research reveals a shared #genetic basis for endometriosis and other types of pain seemingly unrelated to endometriosis. Read more here:https://t.co/IuOLsyHM80
The #changemakers issue from @iamwellandgood features @celmatix founder and CEO, Dr. Piraye Yurttas Beim as a founder driving real progress in #womenshealth. We're proud to be included in their series on the future of wellness.
https://t.co/3ERMqQLDMB
🧬 @celmatix, @bayer & @Evotec just hit another milestone in their quest to develop a first-in-class drug for #PCOS
💬"Novel PCOS drug target progresses into hit-identification."
Full story: https://t.co/pp9DS6nPTT
#womenshealth#biotech
Many modern-day #innovations are born in the #lab.
On 09/08 @ 1 PM ET, join @AtomwiseInc's Abraham Heifets, @CornellEng's Andrea Ippolito, @StrandTx's Jacob Becraft, and @celmatix's Piraye Beim to hear their journeys from #science to #startups: https://t.co/jiRrsCXIbr